Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 1999
Business Overview: The Company manufactures and distributes nutritional supplements through a direct sales network of independent distributors and managers. Operations are segmented into Domestic (U.S.) and International regions (Latin America, Asia Pacific, and Other).
Key Financial Metrics
All amounts in thousands, except per-share data.
| Metric | Three Months Ended Sep 30, 1999 | Nine Months Ended Sep 30, 1999 |
|---|---|---|
| Sales Revenue | $73,240 | $217,056 |
| Net Income | $4,128 | $13,915 |
| Operating Income | $6,192 | $21,232 |
| Diluted EPS | $0.24 | $0.78 |
| Cash and Cash Equivalents (End of Period) | $22,413 | |
| Short-Term Debt | $1,166 | |
| Net Cash Provided by Operating Activities (9mo) | $21,147 |
Material Changes vs. Prior Period
- Revenue Decline: Sales revenue decreased 0.3% in the third quarter and 3.9% for the nine-month period compared to 1998. Management attributes this to increased product/price competition and foreign currency devaluation.
- Profitability Compression: Net income fell 31.9% in the third quarter and 18.3% for the nine-month period year-over-year. Operating income margins declined from 12.1% to 8.5% (Q3) and 11.5% to 9.8% (9mo).
- Expense Increases: Selling, General, and Administrative (SG&A) expenses increased 16.0% in Q3 and 5.5% for the nine months, driven by new marketing initiatives in the U.S. and international expansion (Japan, Korea).
- Foreign Currency Impact: The Brazilian real devalued approximately 61% against the U.S. dollar during the nine-month period, significantly impacting international sales and contributing to a $3.0 million foreign currency translation adjustment loss.
- Share Repurchases: The Company repurchased approximately 779,000 shares of common stock for $8.0 million during the nine-month period.
Outlook, Risks, and Management Commentary
- Guidance: Management expects operating results for Q4 1999 and Q1 2000 to be impacted by continued planned investments in the relaunch of Japanese operations. SG&A expenses are expected to decrease slightly as a percent of sales for the full year 1999.
- Market Conditions: Competition in the nutritional supplement market remains strong. The Company is testing marketing programs to restore growth rates.
- Liquidity: The Company maintains no credit facility but believes working capital requirements can be met through cash and internally generated funds. External funding could be obtained if necessary.
- Year 2000 (Y2K) Risk: The Company believes its systems are Y2K compliant after expending approximately $1.0 million. Primary risks remain potential service disruptions from third-party providers (banking, shipping, utilities).
- Legal: The Company is a defendant in various incidental lawsuits; management does not expect a material effect on financial position.
Investor Verification Checklist
- Verify the sustainability of sales growth in the Asia Pacific segment, which showed significant revenue increases despite broader currency headwinds.
- Monitor the effectiveness of new marketing programs in the domestic market to counteract competitive pressures.
- Assess the impact of the Brazilian real devaluation on future international earnings and the success of price adjustments implemented in March 1999.
- Review the timeline and cost implications of the Japanese market relaunch and its effect on near-term profitability.
- Confirm the status of third-party service provider Y2K compliance to mitigate operational disruption risks.